HT
ATRA icon

HAP Trading’s Atara Biotherapeutics ATRA Stock Holding History

HAP Trading’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-404
Closed -$10K – 1572
2020
Q2 		$10K Sell
404
-96
-19% -$24.3K ﹤0.01% 1444
2020
Q1 		$6K Buy
+500
New +$159K ﹤0.01% 1068
2019
Q4 		– Sell
-7,104
Closed -$62K – 1231
2019
Q3 		$62K Sell
7,104
-7,804
-52% -$2.91M 0.01% 699
2019
Q2 		$365K Buy
14,908
+10,044
+206% +$7.09M 0.03% 394
2019
Q1 		$357K Buy
+4,864
New +$4.52M 0.03% 347
2018
Q3 		– Sell
-3,000
Closed -$122K – 992
2018
Q2 		$122K Sell
3,000
-5,060
-63% -$5.44M 0.01% 539
2018
Q1 		$513K Buy
+8,060
New +$7.34M 0.03% 320

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return